Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ARCTURUS THERAPEUTICS HOLDINGS INC.

(ARCT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Arcturus Therapeutics : Shares Fall After Goldman Sachs Downgrade

08/11/2021 | 01:41pm EDT


ę MT Newswires 2021
All news about ARCTURUS THERAPEUTICS HOLDINGS INC.
10/13ARCTURUS THERAPEUTICS : Announces Approval from Vietnam Ministry of Health to Proceed into..
AQ
10/12ARCTURUS THERAPEUTICS : Secures Vietnam Regulator's Approval to Launch Phase 3b Study of C..
MT
10/12ARCTURUS THERAPEUTICS : Announces Approval from Vietnam Ministry of Health to Proceed into..
BU
10/12Arcturus Therapeutics Holdings Inc. Announces Approval from Vietnam Ministry of Health ..
CI
10/06Combined Market Cap of Top Five mRNA Companies hit $265B, a Fivefold Increase in a Year
AQ
10/05ARCTURUS THERAPEUTICS HOLDINGS INC. : Entry into a Material Definitive Agreement, Creation..
AQ
10/04INSIDER SELL : Arcturus Therapeutics Holdings
MT
09/28GENPREX : Appoints Mark Berger Chief Medical Officer
MT
09/23ARCTURUS THERAPEUTICS : Announces Approval from Vietnam Ministry of Health to Proceed into..
AQ
09/22ARCTURUS THERAPEUTICS : Announces Meeting with President of Vietnam and CEO of Vingroup to..
BU
More news
Analyst Recommendations on ARCTURUS THERAPEUTICS HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2021 56,7 M - -
Net income 2021 -177 M - -
Net cash 2021 278 M - -
P/E ratio 2021 -7,43x
Yield 2021 -
Capitalization 1 199 M 1 199 M -
EV / Sales 2021 16,3x
EV / Sales 2022 2,41x
Nbr of Employees 118
Free-Float 85,1%
Chart ARCTURUS THERAPEUTICS HOLDINGS INC.
Duration : Period :
Arcturus Therapeutics Holdings Inc. Technical Analysis Chart | ARCT | US03969T1097 | MarketScreener
Technical analysis trends ARCTURUS THERAPEUTICS HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Last Close Price 45,56 $
Average target price 78,46 $
Spread / Average Target 72,2%
EPS Revisions
Managers and Directors
Joseph E. Payne President, Chief Executive Officer & Director
Andrew H. Sassine Chief Financial Officer & Director
Peter C. Farrell Chairman
Padmanabh Chivukula Secretary, Chief Operating & Scientific Officer
Steven G. Hughes Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
ARCTURUS THERAPEUTICS HOLDINGS INC.5.03%1 199
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
IQVIA HOLDINGS INC.38.89%47 683
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414